221 related articles for article (PubMed ID: 17009035)
21. [Antitumor and anticachectic activity of UFT in BALB/c mice bearing colon 26 adenocarcinoma].
Nukatsuka M; Fujioka A; Saito H; Nakano K; Uchida J; Oh-ie S; Nomura N; Takeda S; Unemi N; Ishitani K
Gan To Kagaku Ryoho; 1994 Sep; 21(12):2013-20. PubMed ID: 8085852
[TBL] [Abstract][Full Text] [Related]
22. Generation of a humanized monoclonal antibody against human parathyroid hormone-related protein and its efficacy against humoral hypercalcemia of malignancy.
Onuma E; Sato K; Saito H; Tsunenari T; Ishii K; Esaki K; Yabuta N; Wakahara Y; Yamada-Okabe H; Ogata E
Anticancer Res; 2004; 24(5A):2665-73. PubMed ID: 15517871
[TBL] [Abstract][Full Text] [Related]
23. Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen.
Iguchi H; Onuma E; Sato K; Sato K; Ogata E
Int J Cancer; 2001 Oct; 94(1):24-7. PubMed ID: 11668474
[TBL] [Abstract][Full Text] [Related]
24. [Cytokines in experimental cancer cachexia].
Niu Q; Li T; Liu A
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
[TBL] [Abstract][Full Text] [Related]
25. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in the canine anal sac apocrine gland adenocarcinoma (CAC-8) nude mouse model.
Gröne A; Weckmann MT; Blomme EA; Capen CC; Rosol TJ
Vet Pathol; 1998 Sep; 35(5):344-51. PubMed ID: 9754539
[TBL] [Abstract][Full Text] [Related]
26. Induction of parathyroid hormone-related peptide by the Ras oncogene: role of Ras farnesylation inhibitors as potential therapeutic agents for hypercalcemia of malignancy.
Aklilu F; Park M; Goltzman D; Rabbani SA
Cancer Res; 1997 Oct; 57(20):4517-22. PubMed ID: 9377563
[TBL] [Abstract][Full Text] [Related]
27. Role of NF-kappaB and cytokine in experimental cancer cachexia.
Zhou W; Jiang ZW; Tian J; Jiang J; Li N; Li JS
World J Gastroenterol; 2003 Jul; 9(7):1567-70. PubMed ID: 12854165
[TBL] [Abstract][Full Text] [Related]
28. Serum PTHrP Predicts Weight Loss in Cancer Patients Independent of Hypercalcemia, Inflammation, and Tumor Burden.
Hong N; Yoon HJ; Lee YH; Kim HR; Lee BW; Rhee Y; Kang ES; Cha BS; Lee HC
J Clin Endocrinol Metab; 2016 Mar; 101(3):1207-14. PubMed ID: 26765580
[TBL] [Abstract][Full Text] [Related]
29. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice.
Nai YJ; Jiang ZW; Wang ZM; Li N; Li JS
JPEN J Parenter Enteral Nutr; 2007; 31(1):18-25. PubMed ID: 17202436
[TBL] [Abstract][Full Text] [Related]
30. Molecular analysis of xenograft models of human cancer cachexia--possibilities for therapeutic intervention.
Baumgarten AJ; Fiebig HH; Burger AM
Cancer Genomics Proteomics; 2007; 4(3):223-31. PubMed ID: 17878525
[TBL] [Abstract][Full Text] [Related]
31. Herbimycin A, a tyrosine kinase inhibitor, impairs hypercalcemia associated with a human squamous cancer producing interleukin-6 in nude mice.
Moriyama K; Williams PJ; Niewolna M; Dallas MR; Uehara Y; Mundy GR; Yoneda T
J Bone Miner Res; 1996 Jul; 11(7):905-11. PubMed ID: 8797110
[TBL] [Abstract][Full Text] [Related]
32. Establishment and characterization of cachexia-inducing and -non-inducing clones of murine colon 26 carcinoma.
Fujimoto-Ouchi K; Tamura S; Mori K; Tanaka Y; Ishitsuka H
Int J Cancer; 1995 May; 61(4):522-8. PubMed ID: 7759158
[TBL] [Abstract][Full Text] [Related]
33. [PTHrP and cancer cachexia].
Onuma E; Okabe H
Clin Calcium; 2008 Apr; 18(4):489-98. PubMed ID: 18379031
[TBL] [Abstract][Full Text] [Related]
34. Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Endo K; Katsumata K; Iguchi H; Kubodera N; Teramoto T; Ikeda K; Fujita T; Ogata E
J Bone Miner Res; 1998 Sep; 13(9):1378-83. PubMed ID: 9738509
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of experimental cancer cachexia. Local involvement of IL-1 in colon-26 tumor.
Strassmann G; Masui Y; Chizzonite R; Fong M
J Immunol; 1993 Mar; 150(6):2341-5. PubMed ID: 8450216
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo.
Uy HL; Mundy GR; Boyce BF; Story BM; Dunstan CR; Yin JJ; Roodman GD; Guise TA
Cancer Res; 1997 Aug; 57(15):3194-9. PubMed ID: 9242449
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin attenuates cachectic events and decreases production of interleukin-6, a cachexia-inducing cytokine.
Kanzaki M; Soda K; Gin PT; Kai T; Konishi F; Kawakami M
Cytokine; 2005 Dec; 32(5):234-9. PubMed ID: 16338141
[TBL] [Abstract][Full Text] [Related]
38. Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy.
Capparelli C; Kostenuik PJ; Morony S; Starnes C; Weimann B; Van G; Scully S; Qi M; Lacey DL; Dunstan CR
Cancer Res; 2000 Feb; 60(4):783-7. PubMed ID: 10706080
[TBL] [Abstract][Full Text] [Related]
39. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.
Kawamura I; Lacey E; Yamamoto N; Sakai F; Takeshita S; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Shimomura K; Goto T
Anticancer Res; 1999; 19(5B):4105-11. PubMed ID: 10628361
[TBL] [Abstract][Full Text] [Related]
40. [Prolongation of survival and antitumor activity of antitumor drugs in murine cancer cachexia model].
Nukatsuka M; Fujioka A; Saito H; Uchida J; Takeda S; Unemi N
Gan To Kagaku Ryoho; 1996 Jun; 23(7):887-92. PubMed ID: 8678537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
